BTCT
BTC Digital Ltd.
There isn't enough reported data to score BTCT yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BTCT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Strong |
BTCT's revenue and balance sheet are currently strong, but its profitability and cash flow are weak.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BTCT PE Valuation
BTCT has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BTCT Forward outlook
There aren't enough analyst estimates for BTCT to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BTCT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$1.14 | -$0.36 |
BTCT lost $1.14 per share over the past year, a bigger loss than the year before.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BTCT in the latest year-over-year earnings comparison.
BTCT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $4.2M | +0.4% |
| Q3 2025 | $4.2M | +62% |
| Q2 2025 | $2.9M | +23% |
| Q1 2025 | $2.9M | +7.8% |
| Q4 2024 | $4.1M | +338% |
| Q3 2024 | $2.6M | +203% |
| Q2 2024 | $2.3M | -66% |
| Q1 2024 | $2.7M | +183% |
CELH has the stronger quarterly revenue trend. Revenue is up 0.4% for BTCT versus up 17% for CELH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -46% | -35 points |
| Q3 2025 | -46% | -24 points |
| Q2 2025 | -88% | -61 points |
| Q1 2025 | -88% | -47 points |
| Q4 2024 | -11% | +62 points |
| Q3 2024 | -21% | +61 points |
| Q2 2024 | -27% | -25 points |
| Q1 2024 | -40% | +70 points |
BTCT's operating margin was −46% last quarter, down 35 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
BTCT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$13.8M | -$13.2M |
| Q3 2025 | -$3.9M | -$3.6M |
| Q2 2025 | -$3M | -3984% |
| Q1 2025 | -$3M | -$2.6M |
| Q4 2024 | -$537K | -149% |
| Q3 2024 | -$294K | +$69K |
| Q2 2024 | $77K | +$3.6M |
| Q1 2024 | -$433K | -111% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with BTCT at down 189%.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BTCT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +39% | +2.6M shares |
| 3 years | +1271% | +8.7M shares |
BTCT has 9M diluted shares, up 39% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q4 2023 | $329,000 |
| Q3 2023 | — |
| Q2 2023 | — |
BTCT hasn't bought back shares in the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over BTCT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BTCT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -32.7x | Net Cash |
| Q4 2024 | -9.4x | Net Cash |
| Q3 2024 | 0.9x | Very low |
| Q1 2024 | 0.1x | Very low |
| Q4 2023 | 0.0x | Very low |
| Q3 2023 | 0.0x | Very low |
| Q2 2023 | 0.0x | Very low |
| Q1 2023 | -0.1x | Net Cash |
BTCT has more cash than debt.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BTCT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.9 | Neutral |
| Stochastic | 8.4 | Oversold |
BTCT's weekly RSI is 39 (neutral) and its Stochastic is 8 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BTCT PE vs Consumer Defensive Sector
BTCT has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BTCT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.84 | 31% below |
| 20 week MA | $0.96 | 40% below |
| 50 week MA | $1.18 | 51% below |
| 100 week MA | $2.42 | 76% below |
| 200 week MA | $3.11 | 81% below |
BTCT is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over BTCT on trend strength, trading above more of its moving averages.
BTCT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $39.0 | $3.80 | -90% |
| 2023 | $3.80 | $4.82 | +27% |
| 2024 | $4.82 | $4.88 | +1.2% |
| 2025 | $4.88 | $1.60 | -67% |
| 2026 YTD | $1.60 | $0.58 | -64% |
BTCT has finished lower in two of the last four years. It's down 64% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over BTCT on returns for 2026, with the stronger performance.